References: Pentadecapeptide BPC 157 Enhances the Growth Hormone Receptor Expression in Tendon Fibroblasts The effect of pentadecapeptide BPC 157 on hippocampal ischemia/reperfusion injuries in rats Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts
The DSIP nonapeptide is engineered for researchers studying the intersection of neuroendocrinology and physiological recovery
Walker SJ, Plair A, Hemal K et al: Bladder hydrodistention does not result in a significant change in bladder capacity for interstitial cystitis/bladder pain syndrome patients
Research from the original patent holders of BPC-157 suggests the arginate form can boost oral bioavailability from less than 3% to greater than 90%
- The clinical indication for use (e.g., blood-brain barrier disruption, tumor, inflammation) - The MRI or diagnostic procedure associated with the contra,st including date and provider order - The time and route of administration (e.g., IV bolus), and any patient reactions or observations
The label on your B12/MIC vial will always display your prescribed dose